TempraMed Signs Letter of Intent with CPO Cyprus for Exclusive Distribution of VIVI Products in Cyprus

Distribution partnership with one of Cyprus's most established healthcare and consumer-products distributorsHighlights:Toronto, Ontario--(. - September 29, 2026) - TempraMed Technologies Ltd. CSE:VIVI (FSE: 9DY) (OTCQB: TMPTF) ("TempraMed" or the "Company"), a medical-technology innova…